517 related articles for article (PubMed ID: 9830016)
1. Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation.
Qiu WQ; Walsh DM; Ye Z; Vekrellis K; Zhang J; Podlisny MB; Rosner MR; Safavi A; Hersh LB; Selkoe DJ
J Biol Chem; 1998 Dec; 273(49):32730-8. PubMed ID: 9830016
[TBL] [Abstract][Full Text] [Related]
2. Neurons regulate extracellular levels of amyloid beta-protein via proteolysis by insulin-degrading enzyme.
Vekrellis K; Ye Z; Qiu WQ; Walsh D; Hartley D; Chesneau V; Rosner MR; Selkoe DJ
J Neurosci; 2000 Mar; 20(5):1657-65. PubMed ID: 10684867
[TBL] [Abstract][Full Text] [Related]
3. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo.
Farris W; Mansourian S; Chang Y; Lindsley L; Eckman EA; Frosch MP; Eckman CB; Tanzi RE; Selkoe DJ; Guenette S
Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4162-7. PubMed ID: 12634421
[TBL] [Abstract][Full Text] [Related]
4. Purified recombinant insulin-degrading enzyme degrades amyloid beta-protein but does not promote its oligomerization.
Chesneau V; Vekrellis K; Rosner MR; Selkoe DJ
Biochem J; 2000 Oct; 351 Pt 2(Pt 2):509-16. PubMed ID: 11023838
[TBL] [Abstract][Full Text] [Related]
5. BRI2 protein regulates β-amyloid degradation by increasing levels of secreted insulin-degrading enzyme (IDE).
Kilger E; Buehler A; Woelfing H; Kumar S; Kaeser SA; Nagarathinam A; Walter J; Jucker M; Coomaraswamy J
J Biol Chem; 2011 Oct; 286(43):37446-57. PubMed ID: 21873424
[TBL] [Abstract][Full Text] [Related]
6. Statins promote the degradation of extracellular amyloid {beta}-peptide by microglia via stimulation of exosome-associated insulin-degrading enzyme (IDE) secretion.
Tamboli IY; Barth E; Christian L; Siepmann M; Kumar S; Singh S; Tolksdorf K; Heneka MT; Lütjohann D; Wunderlich P; Walter J
J Biol Chem; 2010 Nov; 285(48):37405-14. PubMed ID: 20876579
[TBL] [Abstract][Full Text] [Related]
7. Eicosapentaenoic acid and docosahexaenoic acid increase the degradation of amyloid-β by affecting insulin-degrading enzyme.
Grimm MO; Mett J; Stahlmann CP; Haupenthal VJ; Blümel T; Stötzel H; Grimm HS; Hartmann T
Biochem Cell Biol; 2016 Dec; 94(6):534-542. PubMed ID: 27813426
[TBL] [Abstract][Full Text] [Related]
8. Reduced amyloid-β degradation in early Alzheimer's disease but not in the APPswePS1dE9 and 3xTg-AD mouse models.
Stargardt A; Gillis J; Kamphuis W; Wiemhoefer A; Kooijman L; Raspe M; Benckhuijsen W; Drijfhout JW; Hol EM; Reits E
Aging Cell; 2013 Jun; 12(3):499-507. PubMed ID: 23534431
[TBL] [Abstract][Full Text] [Related]
9. Regulatory feedback cycle of the insulin-degrading enzyme and the amyloid precursor protein intracellular domain: Implications for Alzheimer's disease.
Lauer AA; Mett J; Janitschke D; Thiel A; Stahlmann CP; Bachmann CM; Ritzmann F; Schrul B; Müller UC; Stein R; Riemenschneider M; Grimm HS; Hartmann T; Grimm MOW
Aging Cell; 2020 Nov; 19(11):e13264. PubMed ID: 33128835
[TBL] [Abstract][Full Text] [Related]
10. Degradation of amyloid beta-protein by a metalloprotease secreted by microglia and other neural and non-neural cells.
Qiu WQ; Ye Z; Kholodenko D; Seubert P; Selkoe DJ
J Biol Chem; 1997 Mar; 272(10):6641-6. PubMed ID: 9045694
[TBL] [Abstract][Full Text] [Related]
11. Accumulation of BRI2-BRICHOS ectodomain correlates with a decreased clearance of Aβ by insulin degrading enzyme (IDE) in Alzheimer's disease.
Del Campo M; Stargardt A; Veerhuis R; Reits E; Teunissen CE
Neurosci Lett; 2015 Mar; 589():47-51. PubMed ID: 25597881
[TBL] [Abstract][Full Text] [Related]
12. Medium-Chain Length Fatty Acids Enhance Aβ Degradation by Affecting Insulin-Degrading Enzyme.
Mett J; Lauer AA; Janitschke D; Griebsch LV; Theiss EL; Grimm HS; Koivisto H; Tanila H; Hartmann T; Grimm MOW
Cells; 2021 Oct; 10(11):. PubMed ID: 34831163
[TBL] [Abstract][Full Text] [Related]
13. Degradation of soluble amyloid beta-peptides 1-40, 1-42, and the Dutch variant 1-40Q by insulin degrading enzyme from Alzheimer disease and control brains.
Pérez A; Morelli L; Cresto JC; Castaño EM
Neurochem Res; 2000 Feb; 25(2):247-55. PubMed ID: 10786709
[TBL] [Abstract][Full Text] [Related]
14. Degradation of Alzheimer's Amyloid-β by a Catalytically Inactive Insulin-Degrading Enzyme.
Sahoo BR; Panda PK; Liang W; Tang WJ; Ahuja R; Ramamoorthy A
J Mol Biol; 2021 Jun; 433(13):166993. PubMed ID: 33865867
[TBL] [Abstract][Full Text] [Related]
15. Insulin-signaling Pathway Regulates the Degradation of Amyloid β-protein via Astrocytes.
Yamamoto N; Ishikuro R; Tanida M; Suzuki K; Ikeda-Matsuo Y; Sobue K
Neuroscience; 2018 Aug; 385():227-236. PubMed ID: 29932983
[TBL] [Abstract][Full Text] [Related]
16. Insulin-degrading enzyme sorting in exosomes: a secretory pathway for a key brain amyloid-beta degrading protease.
Bulloj A; Leal MC; Xu H; Castaño EM; Morelli L
J Alzheimers Dis; 2010; 19(1):79-95. PubMed ID: 20061628
[TBL] [Abstract][Full Text] [Related]
17. Insulin-degrading enzyme is not secreted from cultured cells.
Song ES; Rodgers DW; Hersh LB
Sci Rep; 2018 Feb; 8(1):2335. PubMed ID: 29402917
[TBL] [Abstract][Full Text] [Related]
18. GEPT extract reduces Abeta deposition by regulating the balance between production and degradation of Abeta in APPV717I transgenic mice.
Tian J; Shi J; Zhang L; Yin J; Hu Q; Xu Y; Sheng S; Wang P; Ren Y; Wang R; Wang Y
Curr Alzheimer Res; 2009 Apr; 6(2):118-31. PubMed ID: 19355846
[TBL] [Abstract][Full Text] [Related]
19. Effect of growth differentiation factor-15 secreted by human umbilical cord blood-derived mesenchymal stem cells on amyloid beta levels in in vitro and in vivo models of Alzheimer's disease.
Kim DH; Lee D; Lim H; Choi SJ; Oh W; Yang YS; Chang JH; Jeon HB
Biochem Biophys Res Commun; 2018 Oct; 504(4):933-940. PubMed ID: 30224067
[TBL] [Abstract][Full Text] [Related]
20. The extracellular matrix enriched with membrane metalloendopeptidase and insulin-degrading enzyme suppresses the deposition of amyloid-beta peptide in Alzheimer's disease cell models.
Zhang S; Xiao T; Yu Y; Qiao Y; Xu Z; Geng J; Liang Y; Mei Y; Dong Q; Wang B; Wei J; Suo G
J Tissue Eng Regen Med; 2019 Oct; 13(10):1759-1769. PubMed ID: 31151136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
